跳至主要内容
临床试验/ISRCTN75807641
ISRCTN75807641已完成未知

Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease

Boehringer Ingelheim (Canada) Ltd0 个研究点目标入组 6,000 人开始时间: 2002年12月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
6,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adults greater than or equal to 55 years
  • 2. With a history of symptomatic coronary artery disease, cerebrovascular disease, peripheral vascular disease, or diabetes mellitus
  • 3. Without proteinuria
  • 4. Who are intolerant of ACE inhibitors

排除标准

  • Does not comply with the above criteria

研究者

相似试验

进行中(未招募)
不适用
A TElmisartan and AMlodipine STudy to Assess the cardiovascular PROTECTive effects as measured by endothelial dysfunction in hypertensive at risk patients beyond blood pressure - TEAMSTA PROTECT I?Male and female, treated and treatment-naive patients with uncontrolled hypertension (defined as 20/10 mmHg above target BP of <140/90 mmHg [<130/80 mmHg for renally impaired and/ or diabetics patients])?Male and female treated patients with controlled hypertension (defined as target BP < 140/90 mmHg [ < 130/80 mmHg for renally impaired and/ or diabetics patients])MedDRA version: 13.1Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disorders
EUCTR2009-017010-68-DEniversitätsmedizin der Johannes Gutenberg-Universität Mainz
尚未招募
4 期
Randomized clinical trial on efficacy of telmisartan compared to vitamin E on histopathological improvement in patients with nonalcoholic steatohepatitis.onalcoholic steatohepatitis (NASH)
SLCTR/2016/013Bangabandhu Sheikh Mujib Medical University
已完成
不适用
SAPPORO study to Prove the Effects of telmisartan and valsartan on Early morning blood pressure based on amlodipine treatmentpatients with essential hypertension
JPRN-UMIN000003922SPEED investigators250
招募中
不适用
Therapeutic efficacy and safety of telmisartan in patients with non-alcoholic fatty liver disease (NAFLD) and hypertension: exploratory researchon-alcoholic fatty liver disease and hypertension
JPRN-UMIN000020537Department of General Internal Medicine, Kyushu University Hospital50
进行中(未招募)
不适用
Eficacia y seguridad del telmisartan en pacientes hipertensos con insuficiencia renal crónica en hemodiálisisPacientes con insuficiencia renal crónica en programa de hemodiálisis
EUCTR2007-004403-34-ESFundació Puigvert